PPD Executive and Leadership Team

Frank Smith, the Chief Financial Officer at PPD, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, the Chief Financial Officer ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, investor relations, and risk management to support PPD's growth objectives. By optimizing financial strategies, Frank Smith directly contributes to the company's ability to fund innovative research and development initiatives. Ultimately, Smith secures long-term financial stability and enhances shareholder value through disciplined financial oversight. The Chief Financial Officer's guidance is critical for navigating complex market dynamics and maintaining PPD's competitive edge in the contract research sector.

Michael Wilkinson, the Chief Information Officer at PPD, architects and executes the company's global technology strategy. Overseeing all IT infrastructure, cybersecurity, and digital transformation efforts, the Chief Information Officer ensures seamless technological operations supporting drug discovery and development services. This critical role involves managing data integrity, system security, and the implementation of advanced technological solutions to enhance client collaboration and operational efficiency. By driving innovation in IT, Michael Wilkinson directly enables PPD to leverage cutting-edge tools for research and lifecycle management. Ultimately, Wilkinson safeguards sensitive client data and optimizes technological resources to maintain PPD's position as a leading contract research organization. The Chief Information Officer's vision is paramount for maintaining a secure and advanced digital environment.

Keri Henderson, the Clinical Research Vice President & Chief Technology Officer at PPD, spearheads the integration of technology within clinical research operations. Overseeing the development and deployment of innovative technological solutions, the Clinical Research Vice President & Chief Technology Officer ensures PPD's research services remain at the forefront of the industry. This dual role involves driving technological advancements that enhance data collection, analysis, and reporting for pharmaceutical and biotechnology clients. By championing new technologies, Keri Henderson directly accelerates the efficiency and accuracy of drug development pipelines. Ultimately, Henderson enhances PPD's capacity to deliver complex research projects and supports the company's mission to improve global health outcomes. The Clinical Research Vice President & Chief Technology Officer's expertise is vital for maintaining PPD's competitive advantage in research innovation.

Lina Elayyan, the Chief Revenue Officer, Ctc Team & Associate at PPD, drives revenue growth and client acquisition strategies. Overseeing sales operations and fostering key client relationships, the Chief Revenue Officer, Ctc Team & Associate ensures PPD's services meet the evolving needs of pharmaceutical, biotech, and academic organizations. This leadership position involves developing and executing commercial strategies that expand market reach and deepen client engagement across global markets. By optimizing revenue streams, Lina Elayyan directly contributes to PPD's sustained growth and its ability to invest in groundbreaking research initiatives. Ultimately, Elayyan strengthens PPD's market position and enhances its reputation as a premier contract research organization. The Chief Revenue Officer, Ctc Team & Associate's focus is critical for commercial success and client partnership.